Product Portfolio

Randox Biosciences offers an extensive portfolio of over 1,000 products for a multitude of R&D applications including more than 800 monoclonal and polyclonal antibodies and over 400 human recombinant proteins as well as antibody fragments, buffers & diluents and plasma.

Polyclonal Antibodies

Drugs of abuse
  • Alcohol
  • Analgesics
  • Anti-depressants
  • Barbituates
  • Benzodiazepines
  • Hallucinogens
  • Opiates
  • Sedatives
  • Stimulants
  • Synthetic Drugs
  • Therapeutic drugs
Drug Residues
  • Anti-inflammatory Drugs
  • Antimicrobial Drugs
  • Anti-Parasitic Drugs
  • Growth Promoters
  • Mycotoxins
Biochemical markers
  • Biochemical messengers, fatty acid binding proteins and products with applications in the following therapeutic areas;
  • Immunology
  • Oncology
  • Cardiovascular/Cerebrovascular and Metabolic/Nutrition

Monoclonal Antibodies

Drugs of abuse
  • Alcohol, Anti-depressants
  • Barbituates
  • Hallucinogens
  • Opiates, Stimulants
Drug Residues
  • Antimicrobial Drugs
  • Growth Promoters
  • Mycotoxins
Biochemical markers
  • Biochemical messengers, fatty acid binding proteins and products with applications in the following therapeutic areas;
  • Immunology
  • Oncology
  • Cardiovascular/Cerebrovascular and Metabolic/Nutrition

Recombinant Antibody Fragments

  • Single chain variable fragment (scFv’s)

Human Recombinant Proteins

  • Adhesion Molecules
  • Chemokines
  • Cytokines
  • Proteases
  • Tumour markers

Buffers & Diluents

  • Complementary range available

Frozen Human Plasma

  • Available in three formats (Male, Female and Mixed Gender)
  • Highly screened for; HIV, Hepatitis B+C, HTLV I + II, Syphilis, CMV and Procleix WNV


Get in touch to discover more